Patients diagnosed with chronic lymphocytic leukemia who are treated with new targeted agents may have a normal life span, according to John Allan, M.D. Read more
Leandro Cerchietti, M.D., has identified a potential new strategy for the treatment of aggressive diffuse large B-cell lymphomas (DLBCL) called double and triple hit lymphomas. Read more
The lab of Lorraine Gudas, Ph.D., has identified a gene that may provide a new, super specific target for drugs that could stop kidney cancer progression in its tracks. Read more
Senior Scientific, LLC, has established a research collaboration with Weill Cornell Medicine to investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers. Read more
Dean Laurie Glimcher pens a guest piece about the role academic medical centers will have in realizing Vice President Joe Biden's "moonshot to cure cancer" campaign. Read more